FDA Inspection 867390 — Central California Blood Center
The FDA completed an inspection of Central California Blood Center on March 7, 2014 in Fresno, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 7, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fresno, CA (United States)